Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S N Davis

Showing results (11-20 of 63) with videos related to

Pageof 7
Sort By:
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|April 12, 2001
Alteplase activityL C Vermeulen, S N Davis, B S Schwartz
The Journal of Clinical Investigation|July 15, 1997
Prevention of an increase in plasma cortisol during hypoglycemia preserves subsequent counterregulatory responsesS N Davis, C Shavers, B Davis, et al.
Panminerva Medica|October 4, 2013
Sulfonylureas and meglitinides: historical and contemporary issuesE L Lamos, S A Stein, S N Davis
The American Journal of Physiology|March 1, 1989
Effect of blood glucose concentration on osmoregulation in diabetes mellitusC J Thompson, S N Davis, P H Baylis
The Journal of Clinical Investigation|August 1, 1996
Role of cortisol in the pathogenesis of deficient counterregulation after antecedent hypoglycemia in normal humansS N Davis, C Shavers, F Costa, et al.
Diabetes|August 1, 1997
Effects of differing antecedent hypoglycemia on subsequent counterregulation in normal humansS N Davis, C Shavers, R Mosqueda-Garcia, et al.
Diabetes|January 1, 2000
Effects of antecedent hypoglycemia on subsequent counterregulatory responses to exerciseS N Davis, P Galassetti, D H Wasserman, et al.
The Journal of Clinical Endocrinology and Metabolism|January 14, 2000
Effects of gender on neuroendocrine and metabolic counterregulatory responses to exercise in normal manS N Davis, P Galassetti, D H Wasserman, et al.
Clinical Pharmacology and Therapeutics|October 1, 1994
Effect of fasting and obesity in humans on the 6-hydroxylation of chlorzoxazone: a putative probe of CYP2E1 activityD O'Shea, S N Davis, R B Kim, et al.
Diabetes Research and Clinical Practice|January 1, 1994
Exaggerated epinephrine response to hypoglycemia in a physically fit, well-controlled IDDM subjectS N Davis, R E Goldstein, A D Cherrington, et al.
Pageof 7

Showing results (11-20 of 63) with videos related to

Sort By:
Pageof 7
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|April 12, 2001
Alteplase activityL C Vermeulen, S N Davis, B S Schwartz
The Journal of Clinical Investigation|July 15, 1997
Prevention of an increase in plasma cortisol during hypoglycemia preserves subsequent counterregulatory responsesS N Davis, C Shavers, B Davis, et al.
Panminerva Medica|October 4, 2013
Sulfonylureas and meglitinides: historical and contemporary issuesE L Lamos, S A Stein, S N Davis
The American Journal of Physiology|March 1, 1989
Effect of blood glucose concentration on osmoregulation in diabetes mellitusC J Thompson, S N Davis, P H Baylis
The Journal of Clinical Investigation|August 1, 1996
Role of cortisol in the pathogenesis of deficient counterregulation after antecedent hypoglycemia in normal humansS N Davis, C Shavers, F Costa, et al.
Diabetes|August 1, 1997
Effects of differing antecedent hypoglycemia on subsequent counterregulation in normal humansS N Davis, C Shavers, R Mosqueda-Garcia, et al.
Diabetes|January 1, 2000
Effects of antecedent hypoglycemia on subsequent counterregulatory responses to exerciseS N Davis, P Galassetti, D H Wasserman, et al.
The Journal of Clinical Endocrinology and Metabolism|January 14, 2000
Effects of gender on neuroendocrine and metabolic counterregulatory responses to exercise in normal manS N Davis, P Galassetti, D H Wasserman, et al.
Clinical Pharmacology and Therapeutics|October 1, 1994
Effect of fasting and obesity in humans on the 6-hydroxylation of chlorzoxazone: a putative probe of CYP2E1 activityD O'Shea, S N Davis, R B Kim, et al.
Diabetes Research and Clinical Practice|January 1, 1994
Exaggerated epinephrine response to hypoglycemia in a physically fit, well-controlled IDDM subjectS N Davis, R E Goldstein, A D Cherrington, et al.
Pageof 7